GRAL Company Profile and Key Details

GRAIL, Inc. (NASDAQ:GRAL) closed at $54.99 USD, gaining $1.39 (2.59%) from the previous close of $53.60. The stock is currently mid-range between its 52-week high and low $20.44 and $118.84. With a market capitalization of about $2.26 billion, GRAIL, Inc. is classified as a mid-cap and shows higher-than-market volatility (beta ~5.21). Key stats such as the average daily volume over the past year has been around 1.28 million shares, volume is running light vs its 52-week average. Headquartered in Menlo Park, CA, GRAIL, Inc. operates in the Healthcare sector and the Medical - Diagnostics & Research industry. Led by CEO Robert Ragusa, the company employs approximately 1,000 people and listed since June 12, 2024. GRAIL, Inc., a biotechnology company, focuses on developing technologies for early cancer detection.

Short-term trend indicators are mixed aligned (SMA20 -33.79%, SMA50 -37.7%, SMA200 -10.47%). The stock’s 14-day RSI is 34.26 (weak momentum), while the ATR of 10.03 points to higher daily volatility. The stock remains hovering near 52-week lows, trading -51.11% below its high and over 184.25% above its low. Average 10-day trading volume of 761.36 thousand shares is below the 3-month average of 1.27 million, indicating normal recent market interest.

GRAIL, Inc. trades at a P/E ratio of -5.5, slightly below the S&P 500 average, with a price-to-sales ratio of 15.38 and a price-to-book ratio of 0.87 suggesting the stock is closer to book value. The P/FCF stands at -7.57, also below market averages.

GRAIL, Inc. last paid a dividend of 0 per share, Dividend and splits history remains an important factor for investors monitoring long-term returns. A discounted cash flow model estimates fair value at around -$70.29. This means the shares are trading below this model’s fair value.

GRAIL, Inc. generated EPS of -$11.18 over the past year. Five-year average earnings growth is -41.05%. Wall Street analysts project EPS growth of 1.77% annually over the next five years. Analyst sentiment is bullish. Analyst rating data shows there are 2 Strong Buy ratings, 7 Buy ratings, 2 Hold ratings, 0 Sell rating and 0 Strong Sell ratings. Price targets range from $130.00 to $75.00. The high target offers 136.41% upside. The low target suggests 36.39% downside. The mean target is $101.91. This offers 85.32% upside. GRAIL, Inc. earnings surprise history is a mixed track record. The quarter that ended November 12, 2025, missed forecasts by -27.56%. The prior quarter beat by 1.27%. Over the last six quarters, Apple has recorded several small beats. These include -38.72% in November 12, 2024.

GRAIL, Inc. has 36.05 million shares outstanding. The public float is 24.18 million shares, elevated short interest at 15.40% of float. This equals 4.81 million shares. The short ratio is 4.38 days. Institutional investors hold 85.03% of the float. Insiders own 13.81%. ILLUMINA, INC. holds 3.50 million shares, DING CHUN R has 3.31 million shares and RAGUSA ROBERT P has 642.08 thousand shares. Over the past six months, insider transactions show net selling. They sold 1.16 million shares across 17 transactions.